Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Zap your neck, sharpen your mind? new study tests nerve stimulation in vapers

NCT ID NCT06804109

Knowledge-focused Sponsor: Temple University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at whether a mild electrical stimulation of the vagus nerve in the neck can improve attention and thinking in young adults who vape. 100 healthy volunteers aged 18-25 who currently or previously used e-cigarettes will receive either real or fake stimulation, then take three cognitive tests. The goal is to understand if this device can help counteract any mental fogginess linked to vaping.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
non-invasive vagus nerve stimulation (nVNS) device
What this could lead to
If it works, this could point toward a way to help vapers think more clearly.
What could go wrong
This is a small, early-stage study focused on short-term cognitive tests, not health outcomes. The effect may be small or not last.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 100 people

The number the study aims to enrol. It can still change while the study runs.

Started

Mar 2025

Expected to finish

Feb 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 25 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Healthy young adults * Age range 18-25 years * Current or prior users of e-cigarettes Exclusion Criteria: Participants will be excluded from the study if they: * Have any rash, infection, swelling, cut, soreness, drug patch, surgical scar on the neck area * Have any implantable medical device in their body such as a pacemaker, hearing aid implant, or any other metallic/electronic device * Have any hearing or vision problems that are not corrected * Are pregnant or breastfeeding * Have any learning disabilities * Have a medical history of any of the following condition * Meningitis * Traumatic brain injury * Seizure * Syncope * Schizophrenia * Schizoaffective disorder * Bulimia (eating disorder) * Other serious neurological illness * Have a medical history of any of the following cardiac disorder * Carotid atherosclerosis or carotid artery disease * Cervical vagotomy * First degree atrioventricular block or prolonged QT interval * Are taking any medications for to treat hypertension, arrhythmias, or are on calcium channel blockers

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for VAPING are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Vaping

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

VAPING

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Temple University

    RECRUITING

    Philadelphia, Pennsylvania, 19122, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.